Artwork

Content provided by Dr. Synaptologica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Synaptologica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

58. Paragraph 1 of Introduction, written by Nobel Laureates: meaning of each sentence therein

16:51
 
Share
 

Manage episode 494228876 series 3493940
Content provided by Dr. Synaptologica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Synaptologica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Let’s read the first paragraph of the Introduction section in a paper written by the Nobel Laureates. Specifically, we will read each sentence in the paragraph, and think about the meaning and the role of each sentence. One key point is that the structural components of the Abstract will help us understand the paragraphs and sentences of the Introduction.

We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.

Milestone Article 1:

- “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005.

- HTML: https://doi.org/10.1016/j.immuni.2005.06.008

- PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf

- PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/

Copyright of the paper (as of July, 2025):

- See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it).

- Check the “User License” section which lists the “Elsevier user license”:

--- http://www.elsevier.com/open-access/userlicense/1.0/

--- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user

This episode = mini-series: reading-38.

(My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

  continue reading

58 episodes

Artwork
iconShare
 
Manage episode 494228876 series 3493940
Content provided by Dr. Synaptologica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Synaptologica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Let’s read the first paragraph of the Introduction section in a paper written by the Nobel Laureates. Specifically, we will read each sentence in the paragraph, and think about the meaning and the role of each sentence. One key point is that the structural components of the Abstract will help us understand the paragraphs and sentences of the Introduction.

We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.

Milestone Article 1:

- “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005.

- HTML: https://doi.org/10.1016/j.immuni.2005.06.008

- PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf

- PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/

Copyright of the paper (as of July, 2025):

- See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it).

- Check the “User License” section which lists the “Elsevier user license”:

--- http://www.elsevier.com/open-access/userlicense/1.0/

--- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user

This episode = mini-series: reading-38.

(My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

  continue reading

58 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play